Portfolio Update

RNS Number : 5836W
European Opportunities Trust PLC
11 December 2019
 

EUROPEAN OPPORTUNITIES TRUST PLC (the 'Company')

Legal Entity Identifier: 549300XN7RXQWHN18849

             

Month end portfolio information

All data is as at 30 November 2019

 

Top twenty holdings

             

Company

Sector

Country of Listing

% of total assets (including drawn down bank debt)

Wirecard

Information Technology

Germany

11.2%

Novo Nordisk

Health Care

Denmark

8.9%

RELX

Industrials

Netherlands

8.4%

Experian

Industrials

UK

8.1%

Deutsche Boerse

Financials

Germany

6.9%

adidas

Consumer Discretionary

Germany

5.5%

Intermediate Capital

Financials

UK

5.5%

Grenke

Financials

Germany

5.2%

Dassault Systemes

Information Technology

France

5.1%

Amadeus

Information Technology

Spain

5.0%

Grifols

Health Care

Spain

4.6%

Carnival

Consumer Discretionary

UK

4.5%

bioMérieux

Health Care

France

4.5%

Edenred

Industrials

France

3.2%

Genus

Health Care

UK

2.8%

Bayer

Health Care

Germany

1.9%

Arrow Global

Financials

UK

1.5%

Ubisoft

Communication Services

France

1.1%

Infineon

Industrials

Germany

1.1%

Barry Callebaut

Consumer Staples

Switzerland

0.9%

 

Country of listing of investee companies

 

 

% of total assets (including drawn down bank debt)

Germany

32.0%

UK

22.6%

France

15.2%

Denmark

9.5%

Spain

9.5%

Netherlands

8.7%

Switzerland

0.9%

Finland

0.6%

Italy

0.6%

Sweden

0.4%

 

 

 

 

 

Market Capitalisation of investee companies

 

 

% of total assets (including drawn down bank debt)

Large

87.6%

Mid

10.4%

Small

2.1%

             

The Company's most recent report and accounts and further information for shareholders is published on the Company's website at www.europeanopportunitiestrust.com 

 

Enquiries:

 

Devon Equity Management Limited, Company Secretaries to European Opportunities Trust PLC

Richard Pavry

020 3985 0441

enquiries@devonem.com                               

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUBRBDDGXBBGCB
UK 100

Latest directors dealings